Journal of Clinical Virology
Volume 35, Issue 2 , Pages 179-184 , February 2006

Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome

  • Nelson Lee

      Affiliations

    • Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • P.K.S. Chan

      Affiliations

    • Department of Microbiology and School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • Margaret Ip

      Affiliations

    • Department of Microbiology and School of Public Health, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • Eric Wong

      Affiliations

    • Centre for Epidemiology and Biostatistics, School of Public Health, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • Jenny Ho

      Affiliations

    • Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • Catherine Ho

      Affiliations

    • Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • C.S. Cockram

      Affiliations

    • Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • ,
  • David S. Hui

      Affiliations

    • Department of Medicine and Therapeutics, Prince of Wales Hospital, Faculty of Medicine, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, NT, Hong Kong, P.R. China
    • Corresponding Author InformationCorresponding author. Tel.: +852 26322195; fax: +852 26489957.

Received 9 May 2005 ,Revised 7 July 2005 ,Accepted 12 July 2005.

References 

  1. Centers for Disease Control and Prevention (CDC). Severe acute respiratory syndrome (SARS). http://www.cdc.gov/ncidod/sars/lab/biosafety.htm.
  2. Chan PK, Ng KC, Chan RC, Lam RK, Chow VC, Hui M, et al. Immunofluorescence assay for serologic diagnosis of SARS. Emerg Infect Dis. 2004;10(3):530–532
  3. Chan PK, To WK, Ng KC, Lam RK, Ng TK, Chan RC, et al. Laboratory diagnosis of SARS. Emerg Infect Dis. 2004;10(5):825–831
  4. Chen X, Zhou B, Li M, Liang X, Wang H, Yang G, et al. Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J Infect Dis. 2004;189(7):1158–1163
  5. Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24(1):44–46
  6. Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, et al. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis. 2005;191(4):507–514
  7. Gomersall CD, Joynt GM, Lam P, Li T, Yap F, Lam D, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intens Care Med. 2004;30(3):381–387
  8. He Z, Dong Q, Zhuang H, Song S, Peng G, Luo G, et al. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clin Diagn Lab Immunol. 2004;11(4):792–794
  9. Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, et al. SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis. 2003; 9(9):1163–7.
  10. Hsueh PR, Huang LM, Chen PJ, Kao CL, Yang PC. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004;10(12):1062–1066
  11. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005;75(2):185–194
  12. Ip M, Chan PK, Lee N, Wu A, Ng TK, Chan L, et al. Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clin Infect Dis. 2004;38(12):e116–e118
  13. Jan ter Meulen J, Bakker AB, van den Brink EN, Weverling GJ, Martina BE, Haagmans BL, et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet. 2004;363(9427):2139–2141
  14. Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, et al. Characterization of cytokine and chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005;171(8):850–857
  15. Lee HK, Tso EY, Chau TN, Tsang OT, Choi KW, Lai TS. Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerg Infect Dis. 2003;9(11):1491–1492
  16. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. New Engl J Med. 2003;348:1986–1994
  17. Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol. 2004;31(4):304–309
  18. Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003;349(5):508–509
  19. Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis. 2004;190(6):1119–1126
  20. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. HKU/UCH SARS Study Group Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–1772
  21. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349(25):2431–2441
  22. Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10(7):676–678
  23. Sung JJ, Wu A, Joynt GM, Yuen KY, Lee N, Chan PK, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax. 2004;59(5):414–420
  24. Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis. 2005;11(3):411–416
  25. Thein S, Aaskov J, Myint TT, Shwe TN, Saw TT, Zaw A. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J Med Virol. 1993;40(2):102–106
  26. Tso EY, Tsang OT, Lam B, Ng TK, Lim W, Lai TS. Natural course of severe acute respiratory syndrome-associated coronavirus immunoglobulin after infection. J Infect Dis. 2004;190(9):1706–1707
  27. Wilder-Smith A, Teleman MD, Heng BH, Earnest A, Ling AE, Leo YS. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis. 2005;11(7):1142–1145
  28. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95–103
  29. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326(7403):1358–1362
  30. Woo PC, Lau SK, Wong BH, Chan KH, Chu CM, Tsoi HW, et al. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004;11(4):665–668
  31. World Health Organization WHO. http://www.who.int/csr/sars/en/.

PII: S1386-6532(05)00197-6

doi: 10.1016/j.jcv.2005.07.005

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 179-184 , February 2006

Article Tools

* Image Usage & Resolution